Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 521284 22 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113880720A reveals a novel FeCl3-catalyzed reduction for Mirabegron intermediates, offering significant cost reduction and enhanced safety for API manufacturing supply chains.